PSI Structural Biology Knowledgebase

PSI | Structural Biology Knowledgebase
Header Icons
E-Collection

Related Articles
Protein Folding and Misfolding: It's the Journey, Not the Destination
March 2015
CCR5 and HIV Infection
January 2015
HIV/AIDS: Pre-fusion Env Exposed
January 2015
HIV/AIDS: Slide to Enter
January 2015
Updating ModBase
January 2015
Power in Numbers
August 2014
Quorum Sensing: A Groovy New Component
August 2014
Bacterial CDI Toxins
June 2014
Immunity: One Antibody to Rule Them All
June 2014
Virology: A Bat Influenza Hemagglutinin
March 2014
Virology: Making Sensitive Magic
March 2014
Virology: Visualizing Cyanophage Assembly
March 2014
Virology: Zeroing in on HBV Egress
March 2014
Viroporins
March 2014
Cas4 Nuclease and Bacterial Immunity
February 2014
Microbial Pathogenesis: A GNAT from Pseudomonas
February 2014
Microbial Pathogenesis: Targeting Drug Resistance in Mycobacterium tuberculosis
February 2014
Microbiome: The Dynamics of Infection
September 2013
Membrane Proteome: A Funnel-like Viroporin
August 2013
Infectious Diseases: A Pathogen Ubiquitin Ligase
May 2013
Infectious Diseases: A Shared Syringe
May 2013
Infectious Diseases: Determining the Essential Structome
May 2013
Infectious Diseases: Targeting Meningitis
May 2013
NDM-1 and Antibiotics
May 2013
Bacterial Hemophores
January 2013
Microbial Pathogenesis: Computational Epitope Prediction
January 2013
Microbial Pathogenesis: Influenza Inhibitor Screen
January 2013
Microbial Pathogenesis: Measles Virus Attachment
January 2013
Microbial Pathogenesis: NEAT Iron
January 2013
Membrane Proteome: Sphingolipid Synthesis Selectivity
December 2012
A signal sensing switch
September 2012
Gauging needle structure
July 2012
Anthrax Stealth Siderophores
June 2012
A Pseudomonas L-serine dehydrogenase
May 2012
Pilus Assembly Protein TadZ
April 2012
Making Lipopolysaccharide
January 2012
Superbugs and Antibiotic Resistance
December 2011
A change to resistance
November 2011
An effective and cooperative dimer
November 2011
The Perils of Protein Secretion
November 2011
Bacterial Armor
October 2011
Breaking down the defenses
September 2011
Moving some metal
August 2011
Capsid assembly in motion
April 2011
Know thy enemy … structurally
October 2010
Treating sleeping sickness
May 2010
Bacterial spore kinase
April 2010
Hemolysin BL
January 2010
Unusual cell division
October 2009
Anthrax evasion tactics
September 2009
Toxin-antitoxin VapBC-5
September 2009
Antibiotic target
August 2009
Lysostaphin
July 2009
Tackling influenza
June 2009
You look familiar: the Type VI secretion system
June 2009
Unique SARS
April 2009
Anthrax stealth molecule
March 2009
A new class of bacterial E3 ubiquitination enzymes
January 2009
Antiviral evasion
October 2008
SARS connections
September 2008
SARS Coronavirus Nonstructural Protein 1
June 2008

Research Themes Infectious diseases

Microbial Pathogenesis: Influenza Inhibitor Screen

SBKB [doi:10.1038/sbkb.2012.119]
Technical Highlight - January 2013
Short description: A cell-free binding assay is optimized step by step and applied in high throughput to screen for small molecule inhibitors of an influenza protein.

Schematic representation of the FP-based assay to monitor biological interaction. Two ssRNA molecules anneal to form dsRNA and, upon binding of NS1A protein (blue), the FP value increases. If a chemical compound (purple) disrupts this interaction, the FP value decreases. Figure courtesy of Eun Jeong Cho. View full sized image.

Fluorescence polarization (FP) is a robust approach for probing molecular interactions. It is essentially a measure of the tumbling rate of a fluorescently labeled molecule, which increases when the labeled probe binds a large ligand. The measurements are less variable than those based on fluorescence intensity, and the assay is cell-free, rapid and nonradioactive. As such, it has been employed to identify leads in inhibitor screens. The introduction of plate readers with the capacity for high-throughput FP analyses has enabled effective application of this technique in drug discovery.

Ellington, Cho and colleagues, in collaboration with Guy Montelione (PSI NESG), have now developed a FP-based screen to identify inhibitors of nonstructural protein 1 from influenza A virus (NS1A), a key player in viral infection. The N-terminal domain of NS1A nonspecifically binds double-stranded RNA (dsRNA), including viral dsRNAs, preventing their degradation by the human immune system. First, with a fluorescein-labeled dsRNA probe, the authors titrated in a number of NS1A constructs and control proteins, settling on glutathione S-transferase-tagged NS1A for the assay, which exhibited a dose-dependent increase in FP signal. tRNA was included to reduce background, reaction temperature and incubation time were optimized, and the effect of detergent was considered.

Following assay validation, 446 small molecules from the National Institutes of Health Clinical Collection were screened in two 384-well plates, in duplicate. The data were reproducible, with large signal-to-noise ratios. Subsequent stringent hit validation left just one compound, epigallocatechine gallate. This compound, which is found in green tea extract, has been shown to have anti-flu activity in several experiments, corroborating its identification in this screen. Since a structure of the dsRNA-biding site of NS1A is available, the authors suggest structure-based design to optimize the identified inhibitor molecule. As this FP-based assay was robust and reproducible, it should prove effective in the identification of other NS1A inhibitors.

Irene Kaganman

References

  1. E.J. Cho et al. Identification of influenza virus inhibitors targeting NS1A utilizing fluorescence polarization-based high-throughput assay.
    J. Biomol. Screen. 17, 448-459 (2012). doi:10.1177/1087057111431488

Structural Biology Knowledgebase ISSN: 1758-1338
Funded by a grant from the National Institute of General Medical Sciences of the National Institutes of Health